Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
申请人:Garvey S. David
公开号:US20070155781A1
公开(公告)日:2007-07-05
Disclosed are (i) compounds of a steroid, a β-agonist, an anticholinergic, a mast cell stabilizer and a phosphodiesterase (PDE) inhibitor directly or indirectly linked to a NO or NO
2
group or a group which stimulates endogenous production of NO or EDRF in vivo; (ii) compositions of steroids, β-agonists, anticholinergics, mast cell stabilizers and PDE inhibitors, which can optionally be substituted with at least one NO or NO
2
moiety or a group which stimulates endogenous production of NO or EDRF in vivo, and a compound that donates, transfers or releases nitric oxide as a charged species, i.e., nitrosonium (NO
+
) or nitroxyl (NO
−
), or as the neutral species, nitric oxide (NO.) or that stimulates endogenous production of NO or EDRF in vivo; and (iii) uses for them in preventing and/or treating respiratory disorders.
本发明涉及(i)一种类固醇、β-激动剂、抗胆碱能、肥大细胞稳定剂和磷酸二酯酶(PDE)抑制剂的化合物,直接或间接地与NO或NO2基团或在体内刺激内源性NO或EDRF产生的基团相连;(ii)类固醇、β-激动剂、抗胆碱能、肥大细胞稳定剂和PDE抑制剂的组合物,可以选择性地用至少一个NO或NO2基团或在体内刺激内源性NO或EDRF产生的基团替代,以及捐赠、转移或释放硝酸盐(NO+)或亚硝酸盐(NO-)作为带电种或作为中性的一氧化氮(NO.)或在体内刺激内源性NO或EDRF产生的化合物;以及(iii)在预防和/或治疗呼吸系统疾病中使用它们的用途。